Drug Profile
Helicobacter pylori vaccine - GSK
Latest Information Update: 02 Aug 2023
Price :
$50
*
At a glance
- Originator Novartis; University of Siena
- Developer GSK; University of Siena
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Helicobacter infections
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for phase-I development in Helicobacter-infections in Germany (IM)
- 04 Nov 2017 No recent reports of development identified for phase-I development in Helicobacter-infections in Italy (IM)
- 04 Nov 2017 No recent reports of development identified for phase-I development in Helicobacter-infections in Italy (PO)